Jeannot, V., Busser, B., Vanwonterghem, L., Michallet, S., Ferroudj, S., Cokol, M., . . . Hurbin, A. (2016). Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. Onco Targets Ther.

Jeannot, Victor, Benoit Busser, Laetitia Vanwonterghem, Sophie Michallet, Sana Ferroudj, Murat Cokol, Jean-Luc Coll, Mehmet Ozturk, and Amandine Hurbin. "Synergistic Activity of Vorinostat Combined With Gefitinib but Not With Sorafenib in Mutant KRAS Human Non-small Cell Lung Cancers and Hepatocarcinoma." Onco Targets Ther 2016.

Jeannot, Victor, et al. "Synergistic Activity of Vorinostat Combined With Gefitinib but Not With Sorafenib in Mutant KRAS Human Non-small Cell Lung Cancers and Hepatocarcinoma." Onco Targets Ther 2016.